BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $498,000 | +23.6% | 329,000 | 0.0% | 0.00% | – |
| Q4 2014 | $403,000 | +11.6% | 329,000 | 0.0% | 0.00% | – |
| Q3 2014 | $361,000 | +4.3% | 329,000 | 0.0% | 0.00% | – |
| Q2 2014 | $346,000 | -5.5% | 329,000 | 0.0% | 0.00% | – |
| Q1 2014 | $366,000 | +4.0% | 329,000 | 0.0% | 0.00% | – |
| Q4 2013 | $352,000 | – | 329,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |